176 related articles for article (PubMed ID: 32268539)
1. Human DENND1A.V2 Drives
Teves ME; Modi BP; Kulkarni R; Han AX; Marks JS; Subler MA; Windle J; Newall JM; McAllister JM; Strauss JF
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32268539
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype.
McAllister JM; Modi B; Miller BA; Biegler J; Bruggeman R; Legro RS; Strauss JF
Proc Natl Acad Sci U S A; 2014 Apr; 111(15):E1519-27. PubMed ID: 24706793
[TBL] [Abstract][Full Text] [Related]
3. miRNA Profiling Reveals miRNA-130b-3p Mediates DENND1A Variant 2 Expression and Androgen Biosynthesis.
McAllister JM; Han AX; Modi BP; Teves ME; Mavodza GR; Anderson ZL; Shen T; Christenson LK; Archer KJ; Strauss JF
Endocrinology; 2019 Aug; 160(8):1964-1981. PubMed ID: 31184707
[TBL] [Abstract][Full Text] [Related]
4. Alternative splicing of DENND1A, a PCOS candidate gene, generates variant 2.
Tee MK; Speek M; Legeza B; Modi B; Teves ME; McAllister JM; Strauss JF; Miller WL
Mol Cell Endocrinol; 2016 Oct; 434():25-35. PubMed ID: 27297658
[TBL] [Abstract][Full Text] [Related]
5. The PCOS GWAS Candidate Gene
Waterbury JS; Teves ME; Gaynor A; Han AX; Mavodza G; Newell J; Strauss JF; McAllister JM
J Endocr Soc; 2022 Jul; 6(7):bvac078. PubMed ID: 35668995
[TBL] [Abstract][Full Text] [Related]
6. Colocalization of Polycystic Ovary Syndrome Candidate Gene Products in Theca Cells Suggests Novel Signaling Pathways.
Kulkarni R; Teves ME; Han AX; McAllister JM; Strauss JF
J Endocr Soc; 2019 Dec; 3(12):2204-2223. PubMed ID: 31723719
[TBL] [Abstract][Full Text] [Related]
7. Increased protein expression of LHCG receptor and 17α-hydroxylase/17-20-lyase in human polycystic ovaries.
Comim FV; Teerds K; Hardy K; Franks S
Hum Reprod; 2013 Nov; 28(11):3086-92. PubMed ID: 24014605
[TBL] [Abstract][Full Text] [Related]
8. Cellular and Animal Studies: Insights into Pathophysiology and Therapy of PCOS.
Indran IR; Lee BH; Yong EL
Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():12-24. PubMed ID: 27118251
[TBL] [Abstract][Full Text] [Related]
9. The Involvement of Granulosa Cells in the Regulation by Gonadotropins of
Kakuta H; Iguchi T; Sato T
In Vivo; 2018; 32(6):1387-1401. PubMed ID: 30348693
[TBL] [Abstract][Full Text] [Related]
10. The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis.
Wood JR; Nelson VL; Ho C; Jansen E; Wang CY; Urbanek M; McAllister JM; Mosselman S; Strauss JF
J Biol Chem; 2003 Jul; 278(29):26380-90. PubMed ID: 12734205
[TBL] [Abstract][Full Text] [Related]
11. DENND1A gene variants in Bahraini Arab women with polycystic ovary syndrome.
Gammoh E; Arekat MR; Saldhana FL; Madan S; Ebrahim BH; Almawi WY
Gene; 2015 Apr; 560(1):30-3. PubMed ID: 25626177
[TBL] [Abstract][Full Text] [Related]
12. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries.
Nelson VL; Legro RS; Strauss JF; McAllister JM
Mol Endocrinol; 1999 Jun; 13(6):946-57. PubMed ID: 10379893
[TBL] [Abstract][Full Text] [Related]
13. Association analysis between the tag single nucleotide polymorphisms of DENND1A and the risk of polycystic ovary syndrome in Chinese Han women.
Zhu YN; Zhang YT; Liu Q; Shen SM; Zou X; Cao YX; Wang WJ; Yi L; Gao Q; Yang WD; Wang Y
BMC Med Genet; 2020 Jan; 21(1):14. PubMed ID: 31941453
[TBL] [Abstract][Full Text] [Related]
14. Differential association of DENND1A genetic variants with polycystic ovary syndrome in Tunisian but not Bahraini Arab women.
Dallel M; Sarray S; Douma Z; Hachani F; Al-Ansari AK; Letaifa DB; Mahjoub T; Almawi WY
Gene; 2018 Mar; 647():79-84. PubMed ID: 29325736
[TBL] [Abstract][Full Text] [Related]
15. Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome.
Nelson-Degrave VL; Wickenheisser JK; Hendricks KL; Asano T; Fujishiro M; Legro RS; Kimball SR; Strauss JF; McAllister JM
Mol Endocrinol; 2005 Feb; 19(2):379-90. PubMed ID: 15514033
[TBL] [Abstract][Full Text] [Related]
16. Current concepts of polycystic ovary syndrome pathogenesis.
Rosenfield RL
Curr Opin Pediatr; 2020 Oct; 32(5):698-706. PubMed ID: 32889963
[TBL] [Abstract][Full Text] [Related]
17. The mechanism for protein kinase C inhibition of androgen production and 17alpha-hydroxylase expression in a theca cell tumor model.
Beshay VE; Havelock JC; Sirianni R; Ye P; Suzuki T; Rainey WE; Carr BR
J Clin Endocrinol Metab; 2007 Dec; 92(12):4802-9. PubMed ID: 17895316
[TBL] [Abstract][Full Text] [Related]
18. Derailed peripheral circadian genes in polycystic ovary syndrome patients alters peripheral conversion of androgens synthesis.
Johnson BS; Krishna MB; Padmanabhan RA; Pillai SM; Jayakrishnan K; Laloraya M
Hum Reprod; 2022 Jul; 37(8):1835-1855. PubMed ID: 35728080
[TBL] [Abstract][Full Text] [Related]
19. Dennd1a, a susceptibility gene for polycystic ovary syndrome, is essential for mouse embryogenesis.
Shi J; Gao Q; Cao Y; Fu J
Dev Dyn; 2019 May; 248(5):351-362. PubMed ID: 30884041
[TBL] [Abstract][Full Text] [Related]
20. Differential activity of the cytochrome P450 17alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells.
Wickenheisser JK; Quinn PG; Nelson VL; Legro RS; Strauss JF; McAllister JM
J Clin Endocrinol Metab; 2000 Jun; 85(6):2304-11. PubMed ID: 10852468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
